Skip to main content

KRT23 Antibody - BSA Free

Novus Biologicals, part of Bio-Techne | Catalog # NBP1-85597

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP1-85597-25ul
NBP1-85597

Key Product Details

Validated by

Knockout/Knockdown, Independent Antibodies

Species Reactivity

Human

Applications

Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot, Knockdown Validated

Label

Unconjugated

Antibody Source

Polyclonal Rabbit IgG

Format

BSA Free

Concentration

Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.

Product Specifications

Immunogen

This antibody was developed against Recombinant Protein corresponding to amino acids: RLASYLEKVRALEEANMKLESRILKWHQQRDPGSKKDYSQYEENITHLQEQIVDGKMTNAQIILLIDNARMAVDDFNLKYENEHSFKKDLEIEVEGLRRTLDNLTIVTTDLEQEVEGMRKEL

Reactivity Notes

Immunogen displays the following percentage of sequence identity for non-tested species: Mouse (84%), Rat (88%)

Clonality

Polyclonal

Host

Rabbit

Isotype

IgG

Description

Novus Biologicals Rabbit KRT23 Antibody - BSA Free (NBP1-85597) is a polyclonal antibody validated for use in IHC and WB. All Novus Biologicals antibodies are covered by our 100% guarantee.

Scientific Data Images for KRT23 Antibody - BSA Free

Immunohistochemistry-Paraffin: KRT23 Antibody [NBP1-85597]

Immunohistochemistry-Paraffin: KRT23 Antibody [NBP1-85597]

Immunohistochemistry-Paraffin: KRT23 Antibody [NBP1-85597] - Staining of human nasopharynx shows strong cytoplasmic positivity in respiratory epithelial cells.
KRT23 Antibody - BSA Free Western Blot: KRT23 Antibody - BSA Free [NBP1-85597]

Western Blot: KRT23 Antibody - BSA Free [NBP1-85597]

Analysis in Hep-G2 cells transfected with control siRNA, target specific siRNA probe #1, using Anti-KRT23 antibody. Remaining relative intensity is presented. Loading control: Anti-PPIB.
KRT23 Antibody - BSA Free Western Blot: KRT23 Antibody - BSA Free [NBP1-85597]

Western Blot: KRT23 Antibody - BSA Free [NBP1-85597]

Analysis in human cell line HepG2.

Applications for KRT23 Antibody - BSA Free

Application
Recommended Usage

Immunohistochemistry

1:50 - 1:200

Immunohistochemistry-Paraffin

1:50 - 1:200

Western Blot

0.04-0.4 ug/ml
Application Notes
For IHC-Paraffin, HIER pH 6 retrieval is recommended.

Formulation, Preparation, and Storage

Purification

Immunogen affinity purified

Formulation

PBS (pH 7.2) and 40% Glycerol

Format

BSA Free

Preservative

0.02% Sodium Azide

Concentration

Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: KRT23

KRT23 is encoded by this gene is a member of the keratin family. The keratins are intermediate filament proteins responsible for the structural integrity of epithelial cells and are subdivided into cytokeratins and hair keratins. The type I cytokeratins consist of acidic proteins which are arranged in pairs of heterotypic keratin chains. The type I cytokeratin genes are clustered in a region of chromosome 17q12-q21.

Alternate Names

CK23, CK-23, cytokeratin 23, cytokeratin-23, DKFZp434G032, HAIK1, hyperacetylation-inducible type I keratin, K23histone deacetylase inducible keratin 23, keratin 23 (histone deacetylase inducible), keratin, type I cytoskeletal 23, keratin-23, MGC26158, type I intermediate filament cytokeratin

Gene Symbol

KRT23

Additional KRT23 Products

Product Documents for KRT23 Antibody - BSA Free

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for KRT23 Antibody - BSA Free

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...